The NewBeauty Award 2022 Goes to SOFWAVE™ - Best Latest in Ultrasound

Carlifonia, United States - May 10, 2022

Sofwave’s proprietary next-generation ultrasound technology is a significant development toward non-invasive ways to revitalize the skin. The technology has gained recognition and is the recipient of the NewBeauty award.

SOFWAVE™ has been announced as this year’s NewBeauty Award Winner. This award recognizes companies and technologies making a difference in the beauty industry. The accolade is presented to the beauty technology that demonstrates the highest level of innovation and transformation, and this year’s recipient, Sofwave, delivers on both fronts.

SOFWAVE™ has been crowned as the “best latest in ultrasound” thanks to its proprietary next-generation technology. Sofwave technology treats fine lines and wrinkles, lifts eyebrows, and submental and neck lifting using non-invasive ways. The technology is effective on all skin types. Sofwave Medical Ltd is an emerging leader in the beauty industry with non-invasive medical devices that can be used worldwide. Sofwave technology provides innovative energy-based skin stimulation for collagen production that helps revitalize the skin.

With advances in technology and trends changing fast, many outstanding new introductions to the beauty space have emerged. However, Sofwave technology beats them all for first place thanks to its Synchronous Ultrasound Parallel Beam technology. Lina Omari, Chief Digital Officer at Sofwave, said of the award, “we are thrilled to have received industry experts’ accolades. This highly coveted industry win further solidifies that Sofwave delivers exceptional results to physicians and their patients.”

Where cosmetic procedures for wrinkle reduction and lifting the eyebrow have been invasive in the past, Sofwave uses its next-generation ultrasound technology to reach deeper layers of the skin and stimulate collagen production. The technology is FDA cleared, and its efficiency has been proven through multiple happy clients. Sofwave also has clearance for a non-invasive dermatological aesthetic treatment for facial lines and wrinkles. Following the award, Sofwave’s Chief Executive Officer Louis Scafuri also noted that the company would continue working on innovative products that meet people and customers' needs and advance the medical aesthetics industry.

By providing a non-invasive alternative to people, Sofwave has made it possible for people to look and feel their best in no time. Sofwave ultrasound treatment begins to take effect as fast as the first treatment, with each session lasting 30-45 minutes. “This non-surgical approach is designed to achieve ideal outcomes with minimal downtime. This innovative treatment option is fast becoming the gold standard for plastic surgeons who are recommending Sofwave treatments to patients looking for non-surgical procedures for lifting the eyebrow, wrinkle reduction, and other facial and submental treatments.”

In addition to being effective, Sofwave treatments are also safe, ensuring the outer skin layer doesn’t burn during the procedure. This is achieved with an integrated cooling mechanism in their ultrasound, SofcoolTM. “Patients love that Sofwave™ is non-invasive and can fit into an active lifestyle. Patients can have the ultrasound treatment and go back to their daily activities immediately.”

About Sofwave

SOFWAVE™ provides cutting-edge next-generation ultrasound technology that introduces a new non-invasive approach to wrinkle reduction and lifting. Sofwave’s Synchronous Ultrasound Parallel Beam Technology SUPERB is FDA cleared, providing plastic surgeons everywhere with an intelligent, effective, and safe treatment for their patients. The technology is also clinically proven to remodel collagen, revitalizing skin by improving facial lines and wrinkles, submental neck area, and lifting the eyebrows.

Contact Info:
Name: Bella
Email: Send Email
Organization: SOFWAVE™
Address: United States
Website: https://sofwave.com

Release ID: 89074651

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.